Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 6, 2007, Pages 701-705

  Väyrynen, Wilma ^a   Heikinheimo, Oskari ^a   Nuutila, Mika ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Intrauterine fetal death; Mifepristone; Misoprostol

Indexed keywords

ANTIBIOTIC AGENT; MIFEPRISTONE; MISOPROSTOL; OXYTOCIN;

ADOLESCENT; ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DELIVERY; DRUG EFFICACY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; INTERMETHOD COMPARISON; LABOR INDUCTION; MAJOR CLINICAL STUDY; MONOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ADOLESCENT; ADULT; DRUG THERAPY, COMBINATION; FEMALE; FETAL DEATH; HUMANS; LABOR, INDUCED; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 34249075122     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701379853     Document Type: Article

References (16)

1. Knochenour NK. Management of fetal demise. Clin Obstet Gynecol. 1987;30:322-4.
2. Ngai SW, Tang OS, Ho PC. Prostaglandins for induction of second-trimester termination and intrauterine death. Best Pract Res Clin Obstet Gynaecol. 2003;17:765-5. Review.
3. Bugalho A, Bique C, Machungo F, Faundes A. Induction of labor with intravaginal misoprostol in intrauterine fetal death. Am J Obstet Gynecol. 1994;171:538-1.
4. Fletcher HM, Wharfe G, Simeon D, Mitchell S, Brown D. Induction of labour with intravaginal misoprostol versus dinoprostone in intrauterine death: a retrospective study. J Obstet Gynaecol. 1996;16:155-8.
5. Draycott T, Hawkes N, Read MD. Induction of labour with vaginal misoprostol after intrauterine death from 24 weeks gestation. J Obstet Gynaecol. 1996;16:517-8.
6. Chittacharoen A, Herabutya Y, Punyavachira P. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstet Gynecol. 2003;101:70-3.
7. De Heus R, Graziosi GC, Christiaens GC, Bruinse HW, Mol BW. Medical management for termination of second and third trimester pregnancies: a comparison of strategies. Eur J Obstet Gynecol Reprod Biol. 2004;116:16-21.
8. Dodd J, O'Brien L, Coffey J. Misoprostol for second and third trimester termination of pregnancy: a review of practice at the Women's and Children's Hospital, Adelaide, Australia. Aust N Z J Obstet Gynaecol. 2005;45:25-9.
9. Jannet D, Aflak N, Abankwa A, Carbonne B, Marpeau L, Milliez J. Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol. Eur J Obstet Gynecol Reprod Biol. 1996;70:159-63.
10. Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. Br J Obstet Gynaecol. 2002;109:443-7.
11. Fairley TE, Mackenzie M, Owen P, Mackenzie F. Management of late intrauterine death using a combination of mifepristone and misoprostol - experience of two regimens. Eur J Obstet Gynecol Reprod Biol. 2005;118:28-31.
12. Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol. 1964;24:266-8.
13. Heikinheimo O, Suhonen S, Haukkamaa M. One- and 2-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy. Reprod Biomed Online. 2004;8:236-9.
14. Swahn ML, Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol. 1988;95:126-34.
15. Giacalone PL, Daures JP, Faure JM, Boulot P, Hedon B, Laffargue F. The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns. Eur J Obstet Gynecol Reprod Biol. 2001;97:30-4.
16. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med. 2001;344:38-47. Review.